Product Details
| Product Name:
Eprociclovir |
CAS No.:
145512-85-2 |
| Purity:
99.86% |
Supply Ability:
10g |
| Release date:
2025/11/09 |
Product Introduction
Bioactivity
| Name | Eprociclovir |
| Description | Eprociclovir (A-5021) is a novel acyclovir analog that is a potent inhibitor of EHV1 replication and may be used for the treatment and/or prevention of infections with this virus.Eprociclovir has potent anti-herpetic activity against most human herpesviruses. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | Eprociclovir | Antiherpetic |
| Inhibitors Related | Quinizarin | Adenine hemisulfate | Rifaximin | Metronidazole | Guanidine hydrochloride | Methotrexate disodium | L-Lysine | Adenine | Carbazole | Thymidine | Docosanoic acid | Dihydromyricetin |
| Related Compound Libraries | Bioactive Compound Library | Anti-Viral Compound Library | Inhibitor Library | Bioactive Compounds Library Max | Anti-Infection Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:2624131-45-7
$31.00 / 1mg
-
CAS:72896-40-3
$129.00 / 1mg
-
CAS:2243736-37-8
$139.00 / 1mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$2980.00/50mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-07-28 |